Valuing Mortality Risk Reductions
2019
This article and the accompanying working paper[1] review the literature and develop recommendations for valuing mortality risk reductions in benefit-cost analyses that address low- and middle-income countries. Increasing life expectancy is a major goal of many policies implemented around the world. As a result, the value of reducing mortality risks has been extensively studied and several organizations have developed recommendations for estimating these values. However, both the recommendations and the underlying research primarily address high-income settings, raising questions about the extent to which the results are applicable in low- and middle-income countries. The recommendations are also diverse, reflecting differing methodological choices as well as differing policy contexts. To address related uncertainties and promote comparability across studies, this paper recommends that analysts conduct a standardized sensitivity analysis that uses a common range of default values.
The working paper supplements the published article, providing more information on the underlying research.
Source [1]: Robinson LA, Hammitt JK, O'Keeffe L. Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis. Guidelines for Benefit-Cost Analysis Project Working Paper No. 7, 2018. https://media.repository.chds.hsph.harvard.edu/static/filer_public/9b/f7/9bf725e4-0c63-4c52-894b-719bb27eba6e/2018_robinson_bca_mort_risk_red_bca_prj_wp_66.pdf
Valuing Mortality Risk Reductions
Source:
Robinson LA, Hammitt JK, O’Keeffe L. Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis. Journal of Benefit-Cost Analysis 2019; 10 (S1): 15-50. https://doi.org/10.1017/bca.2018.26